ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dexmedetomidine Alleviates LPS-Induced Neuronal Dysfunction by Modulating the AKT/GSK-3β/CRMP-2 Pathway in Hippocampal Neurons

Zeng, Wei; Zhang, Chunyuan; Long, Qingshan; Li, Yalan*广州医学院; 南方医科大学; 1
Neuropsychiatric Disease and Treatment2021DOI: 10.2147/NDT.S297365
5被引12阅读
引用收藏
分享

摘要

Objective: Dexmedetomidine, an ?2-adrenergic receptor agonist, mitigates cognitive dysfunction in elderly patients after surgery with general anesthesia. However, the underlying mechanism by which dexmedetomidine reduces cognitive dysfunction remains to be fully elucidated. The aim of this study was to investigate the effects of dexmedetomidine on lipopolysaccharide (LPS)-induced neuronal dysfunction in cultured hippocampal neurons. Methods: LPS, in the presence and absence of dexmedetomidine, was applied to cultured hippocampal neurons to mimic post-surgical inflammation. Neuronal morphology, including neurite outgrowth and synaptic transmission, was observed, and miniature excitatory post synaptic currents were recorded by electrophysiological patch-clamp. Results: LPS significantly impaired neurite outgrowth in hippocampal neurons in a concentration-and time-dependent manner, which was reversed by dexmedetomidine treatment. Electrophysiological patch-clamp results showed that LPS induced synaptic transmission dysfunction, which was restored after dexmedetomidine addition. Furthermore, Western blotting assays showed that LPS suppressed the AKT/GSK-3?/CRMP-2 signaling pathway and dexmedetomidine countered the inhibitory effect of LPS by re-activating this pathway. Conclusion: In general, dexmedetomidine protected against the effects of LPS-induced hippocampal neuron damage, including neurite outgrowth and synaptic transmission. Overall, dexmedetomidine modulated the AKT/GSK-3?/CRMP-2 signaling pathway to alleviate LPS-induced neurological dysfunction.

学科与关键词

关键词
dexmedetomidinepostoperative cognitive dysfunctionneurological impairmentAKTGSK-3CRMP-2
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Neuropsychiatric Disease and Treatment
发表日期
2021
卷期
第 17 卷
页码
671-680
DOI
10.2147/NDT.S297365
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
Medical Scientific Research Foundation of Guangdong Province, China [B2021190]

作者

  • Z

    Zeng, Wei (第一作者)

    1 · southern med univ

  • Z

    Zhang, Chunyuan

    southern med univ

查看全部 4 位作者收起作者
  • L

    Long, Qingshan

    guangzhou med univ

  • L

    Li, Yalan (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417